Ketoconazol Cinfa (Ketoconazole)

Ketoconazole blocks the fungal enzyme lanosterol 14α‑demethylase, which is essential for synthesising ergosterol, a key component of the fungal cell membrane. Inhibiting ergosterol production weakens the membrane, leading to increased permeability and fungal cell death, thereby clearing the infection.

The amount of Ketoconazol Cinfa to apply, the frequency of application, and the duration of therapy are determined by the prescribing healthcare professional based on the specific infection, its severity, the patient’s age, and the area of skin involved. Patients should follow the prescriber’s instructions exactly.

Safety data for topical ketoconazole in pregnancy and lactation are limited. Because the risk cannot be ruled out, it should be used only if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their clinician.

To order Ketoconazol Cinfa, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details and any necessary import documentation.

Ketoconazol is an azole class antifungal, offering broad‑spectrum activity against dermatophytes and yeasts. Compared with allylamine agents such as terbinafine, ketoconazole has a similar efficacy for many skin infections but may be chosen for its anti‑inflammatory properties in seborrheic dermatitis. Choice depends on infection type, patient tolerance and prescriber preference.

Ketoconazol Cinfa should be stored at room temperature, below 25 °C (77 °F). Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use to maintain stability.

Apply a thin layer of the cream or gel to the affected skin area once or twice daily, as directed by the prescriber. Gently rub it in until it disappears, and wash hands before and after application unless the hands are the treatment site. Avoid covering the treated area with airtight dressings unless instructed.

Although rare, serious adverse reactions can include severe contact dermatitis, extensive skin rash, or systemic effects such as hepatic toxicity if large skin areas are treated and significant absorption occurs. Patients should stop use and seek medical attention if they notice swelling, jaundice, or any signs of an allergic reaction.

Ketoconazol Cinfa should not be used by individuals with a known hypersensitivity to ketoconazole or any component of the formulation. It is also contraindicated on extensive broken skin, in patients with severe liver disease, or in those who have experienced severe reactions to other topical azole antifungals.